In silico medicine & beyond: a new VPH chapter

The future of medicine is digital, predictive, and powered by simulation.

On 19 November 2025 3-4pm CET, join us online for:

In silico medicine & beyond: a new VPH chapter

This event will bring together thought leaders shaping the future of healthcare. We’ll explore how in silico medicine is transforming research, regulation, and clinical practice, and where the Virtual Physiological Human (VPH) community fits into this evolution.

Speakers will include voices from across the ecosystem: regulators, clinicians, industry, and patient organisations, ensuring a rich, multidisciplinary perspective on the future of healthcare.

• Liesbet Geris, VPH Director, will present a forward-looking vision for VPH and in silico medicine over the next decade.
• Tina Morrison, VP & Scientific Strategist at EQTY Labs, and formerly Science Advisor to FDA Chief Scientist at the FDA. At our event, she will share her insights on regulatory aspects and the vision for in silico medicine, highlighting how smart regulations and trust can accelerate innovation while ensuring safety and efficacy.
• Steven Bourke, Founder and CEO of PersonalPulse, a consulting firm driving transformation in citizen-led healthcare innovation. With over 20 years of experience, Steven champions strategic, value-based co-creation across healthcare systems.
• Eric Vibert, surgeon specialised in digital solutions in the operating theatre, working at Paul Brousse Hospital, Paris, and a professor at Paris Saclay University and INSERM. At our event, he will share the clinician’s perspective on in silico medicine, showing how simulation and digital tools are transforming surgical care.

And at the end of the program, we’ll unveil something special: a new route designed to reflect our growth, our multidisciplinary community, and our vision for the future.